Xylo Technologies (XYLO) Stock Price, News & Analysis

Company Overview

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Key Stats

• Today's Range: $5.19 to $5.49
• 50-Day Range: $3.88 to $5.53
• 52-Week Range: $2.70 to $8.83
• Volume: 2,290 shs
• Average Volume: 20,463 shs
• Market Capitalization: $4.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Xylo Technologies Stock Analysis - MarketRank™

Xylo Technologies scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Xylo Technologies.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Xylo Technologies has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.33% of the float of Xylo Technologies has been sold short.

Short Interest Ratio / Days to Cover

Xylo Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Xylo Technologies has recently decreased by 67.11%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Xylo Technologies does not currently pay a dividend.

Dividend Growth

Xylo Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.33% of the float of Xylo Technologies has been sold short.

Short Interest Ratio / Days to Cover

Xylo Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Xylo Technologies has recently decreased by 67.11%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Xylo Technologies has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Xylo Technologies this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Xylo Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.19% of the stock of Xylo Technologies is held by insiders.

Percentage Held by Institutions

Only 0.26% of the stock of Xylo Technologies is held by institutions.

XYLO Stock Analysis - Frequently Asked Questions

How have XYLO shares performed this year?

Xylo Technologies' stock was trading at $3.62 at the beginning of the year. Since then, XYLO shares have increased by 46.3% and is now trading at $5.2960.
View the best growth stocks for 2025 here.

When did Xylo Technologies' stock split?

Xylo Technologies's stock reverse split on the morning of Monday, August 5th 2024. The 1-2.666666 reverse split was announced on Monday, August 5th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 38 shares after the split.

How do I buy shares of Xylo Technologies?

Shares of XYLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Xylo Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Xylo Technologies investors own include Upexi (UPXI), Tesla (TSLA), Siyata Mobile (SYTA), Soluna (SLNH), Rexahn Pharmaceuticals (REXN), NRx Pharmaceuticals (NRXP) and NeuroOne Medical Technologies (NMTC).

Company Calendar

• Today: 5/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:XYLO
• Previous Symbol: NASDAQ:XYLO
• CIK: 1618500
• Web: www.medigus.com
• Phone: 972-3689-9124
• Fax: 972-8853-8194
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 0.95
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $57.64 million
• Price / Sales: 0.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $46.35 per share
• Price / Book: 0.11

Miscellaneous

• Outstanding Shares: 826,000
• Free Float: 705,000
• Market Cap: $4.37 million
• Optionable: Optionable
• Beta: 0.49